Targeted protein degradation is only the beginning. Blazing a new path in medicine.
research • life sciences • biotechnology
201 - 500
💰 $40M Post-IPO Equity on 2022-07
12 hours ago
🏢 In-office - San Francisco
⏰ Full Time
🟠 Senior
🛂 H1B Visa Sponsor
🟢 Junior
🟡 Mid-level
September 6
⚙️ Systems Engineer
AWS
Cloud
ERP
⏳ Contract/Temporary
✏️ Content Writer
August 30
🔴 Lead
👷♀️ Project Manager
July 8
⚙️ Operations